CytoDyn Inc.

07/22/2021 | Press release | Distributed by Public on 07/22/2021 15:26

CytoDyn will seek FDA guidance on proceeding with an expedited regulatory plan for approval of leronlimab with existing FDA Fast Track designation for mTNBC (Form 8-K)